Literature DB >> 15326130

Defining the pathogenicity of optineurin in juvenile open-angle glaucoma.

Colin E Willoughby1, Louie Loh Yen Chan, Sarah Herd, Gail Billingsley, Nima Noordeh, Alex V Levin, Yvonne Buys, Graham Trope, Mansoor Sarfarazi, Elise Héon.   

Abstract

PURPOSE: Juvenile open-angle glaucoma (JOAG) differs from primary open-angle glaucoma in that it is usually a more severe phenotype and has an earlier age of onset. Optineurin was recently associated with a variant of POAG that is characterized by intraocular pressure within normal limits: normal-tension glaucoma. The present study tested whether OPTN sequence changes play a role in early-onset glaucoma characterized by elevated intraocular pressure.
METHODS: Sixty-six patients with JOAG characterized by high intraocular pressure were screened for mutations. Mutational analysis was performed with a combination of restriction enzyme digestion, single-strand conformation polymorphism, and direct sequencing. The effects of select changes on exon splicing were assessed using bioinformatic modeling approaches and RT-PCR.
RESULTS: Ten sequence changes were identified, of which H486R was strongly suggestive of pathogenicity. H486R represents the first reported OPTN mutation associated with JOAG. Also, L41L is proposed to confer an increased susceptibility to the development of JOAG. Most of the other sequence changes observed were not thought to be biologically significant. The frequency of the previously reported M98K allele was not increased in the JOAG population studied but showed the previously reported skewed distribution in the POAG study population. The changes identified were not shown to affect the splicing machinery.
CONCLUSIONS: The results of this work support the hypothesis that mutations in OPTN are not specifically associated with low-pressure glaucoma, but can play a role in JOAG. Copyright Association for Research in Vision and Ophthalmology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15326130     DOI: 10.1167/iovs.04-0107

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  18 in total

Review 1.  Cellular and molecular biology of optineurin.

Authors:  Hongyu Ying; Beatrice Y J T Yue
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 2.  Optineurin: The autophagy connection.

Authors:  Hongyu Ying; Beatrice Y J T Yue
Journal:  Exp Eye Res       Date:  2015-07-02       Impact factor: 3.467

3.  Overexpressed mutant optineurin(E50K) induces retinal ganglion cells apoptosis via the mitochondrial pathway.

Authors:  Qingfeng Meng; Jia Lv; Hongyan Ge; Lu Zhang; Fei Xue; Yuanmao Zhu; Ping Liu
Journal:  Mol Biol Rep       Date:  2012-03-16       Impact factor: 2.316

4.  The role of the Met98Lys optineurin variant in inherited optic nerve diseases.

Authors:  J E Craig; A W Hewitt; D P Dimasi; N Howell; C Toomes; A C Cohn; D A Mackey
Journal:  Br J Ophthalmol       Date:  2006-08-02       Impact factor: 4.638

5.  Transgenic mice with overexpression of mutated human optineurin(E50K) in the retina.

Authors:  Qingfeng Meng; Zheng Xiao; Huiping Yuan; Fei Xue; Yuanmao Zhu; Xinrong Zhou; Binbin Yang; Jingbo Sun; Bo Meng; Xian Sun; Fang Cheng
Journal:  Mol Biol Rep       Date:  2011-06-17       Impact factor: 2.316

Review 6.  Juvenile-onset open-angle glaucoma - A clinical and genetic update.

Authors:  Harathy Selvan; Shikha Gupta; Janey L Wiggs; Viney Gupta
Journal:  Surv Ophthalmol       Date:  2021-09-16       Impact factor: 6.197

7.  Structural insights into the ubiquitin recognition by OPTN (optineurin) and its regulation by TBK1-mediated phosphorylation.

Authors:  Faxiang Li; Daichao Xu; Yingli Wang; Zixuan Zhou; Jianping Liu; Shichen Hu; Yukang Gong; Junying Yuan; Lifeng Pan
Journal:  Autophagy       Date:  2018-02-02       Impact factor: 16.016

8.  Optineurin is required for CYLD-dependent inhibition of TNFα-induced NF-κB activation.

Authors:  Ananthamurthy Nagabhushana; Megha Bansal; Ghanshyam Swarup
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240

Review 9.  Common and rare myocilin variants: Predicting glaucoma pathogenicity based on genetics, clinical, and laboratory misfolding data.

Authors:  Hailee F Scelsi; Brett M Barlow; Emily G Saccuzzo; Raquel L Lieberman
Journal:  Hum Mutat       Date:  2021-06-24       Impact factor: 4.700

10.  Role of CYP1B1, MYOC, OPTN, and OPTC genes in adult-onset primary open-angle glaucoma: predominance of CYP1B1 mutations in Indian patients.

Authors:  Arun Kumar; Manjunath G Basavaraj; Santosh K Gupta; Imteyaz Qamar; Abdullah Mahmood Ali; Vineeta Bajaj; T K Ramesh; D Ravi Prakash; Jyoti S Shetty; Syril K Dorairaj
Journal:  Mol Vis       Date:  2007-04-30       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.